The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and children aged 9 years and older.

Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...

Guselkumab treatment was associated with improvements in 3 biomarkers associated with systemic inflammation among patients with plaque psoriasis.

Let’s discuss four foods to avoid with psoriasis that may be affecting your skin, along with healthier substitutes.

Accropeutics’ oral, selective TYK2/JAK1 inhibitor AC-201 has met the primary and key secondary endpoints in a Phase II ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers ...

Treatment with guselkumab among patients with psoriasis does not contribute to the risk for or progression of liver fibrosis.

The dosing interval for ixekizumab may be extended in some patients with plaque psoriasis, and switching between biologics ...

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

That's where a salicylic acid shampoo comes in. Like a dandruff shampoo, these formulas can help relieve dryness, flakes, and ...